These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 38799637)

  • 1. The inhibitory effect of adenosine on tumor adaptive immunity and intervention strategies.
    Wang L; Zhang J; Zhang W; Zheng M; Guo H; Pan X; Li W; Yang B; Ding L
    Acta Pharm Sin B; 2024 May; 14(5):1951-1964. PubMed ID: 38799637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory effect of adenosine on adaptive antitumor immunity and intervention strategies.
    Wang L; Zhang W; Zhang J; Zheng M; Pan X; Guo H; Ding L
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2023 Sep; 52(5):567-577. PubMed ID: 37916308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenosine mediates functional and metabolic suppression of peripheral and tumor-infiltrating CD8
    Mastelic-Gavillet B; Navarro Rodrigo B; Décombaz L; Wang H; Ercolano G; Ahmed R; Lozano LE; Ianaro A; Derré L; Valerio M; Tawadros T; Jichlinski P; Nguyen-Ngoc T; Speiser DE; Verdeil G; Gestermann N; Dormond O; Kandalaft L; Coukos G; Jandus C; Ménétrier-Caux C; Caux C; Ho PC; Romero P; Harari A; Vigano S
    J Immunother Cancer; 2019 Oct; 7(1):257. PubMed ID: 31601268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenosine can thwart antitumor immune responses elicited by radiotherapy : Therapeutic strategies alleviating protumor ADO activities.
    Vaupel P; Multhoff G
    Strahlenther Onkol; 2016 May; 192(5):279-87. PubMed ID: 26961686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small molecule AZD4635 inhibitor of A
    Borodovsky A; Barbon CM; Wang Y; Ye M; Prickett L; Chandra D; Shaw J; Deng N; Sachsenmeier K; Clarke JD; Linghu B; Brown GA; Brown J; Congreve M; Cheng RK; Dore AS; Hurrell E; Shao W; Woessner R; Reimer C; Drew L; Fawell S; Schuller AG; Mele DA
    J Immunother Cancer; 2020 Jul; 8(2):. PubMed ID: 32727810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ATP and Its Metabolite Adenosine as Regulators of Dendritic Cell Activity.
    Silva-Vilches C; Ring S; Mahnke K
    Front Immunol; 2018; 9():2581. PubMed ID: 30473700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The yin and yang functions of extracellular ATP and adenosine in tumor immunity.
    Feng LL; Cai YQ; Zhu MC; Xing LJ; Wang X
    Cancer Cell Int; 2020; 20():110. PubMed ID: 32280302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unlocking antitumor immunity with adenosine receptor blockers.
    Remley VA; Linden J; Bauer TW; Dimastromatteo J
    Cancer Drug Resist; 2023; 6(4):748-767. PubMed ID: 38263981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overcoming high level adenosine-mediated immunosuppression by DZD2269, a potent and selective A2aR antagonist.
    Bai Y; Zhang X; Zheng J; Liu Z; Yang Z; Zhang X
    J Exp Clin Cancer Res; 2022 Oct; 41(1):302. PubMed ID: 36229853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcium Phosphate-Reinforced Metal-Organic Frameworks Regulate Adenosine-Mediated Immunosuppression.
    Liang L; Yang LL; Wang W; Ji C; Zhang L; Jia Y; Chen Y; Wang X; Tan J; Sun ZJ; Yuan Q; Tan W
    Adv Mater; 2021 Nov; 33(45):e2102271. PubMed ID: 34554618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Augmenting Anticancer Immunity Through Combined Targeting of Angiogenic and PD-1/PD-L1 Pathways: Challenges and Opportunities.
    Hack SP; Zhu AX; Wang Y
    Front Immunol; 2020; 11():598877. PubMed ID: 33250900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenosine in cancer immunotherapy: Taking off on a new plane.
    Zhang C; Wang K; Wang H
    Biochim Biophys Acta Rev Cancer; 2023 Nov; 1878(6):189005. PubMed ID: 37913941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reshaping hypoxia and silencing CD73 via biomimetic gelatin nanotherapeutics to boost immunotherapy.
    Yuan CS; Teng Z; Yang S; He Z; Meng LY; Chen XG; Liu Y
    J Control Release; 2022 Nov; 351():255-271. PubMed ID: 36165836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting purinergic pathway to enhance radiotherapy-induced immunogenic cancer cell death.
    Bao X; Xie L
    J Exp Clin Cancer Res; 2022 Jul; 41(1):222. PubMed ID: 35836249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multifaceted Effects of Extracellular Adenosine Triphosphate and Adenosine in the Tumor-Host Interaction and Therapeutic Perspectives.
    de Andrade Mello P; Coutinho-Silva R; Savio LEB
    Front Immunol; 2017; 8():1526. PubMed ID: 29184552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strategies to overcome myeloid cell induced immune suppression in the tumor microenvironment.
    Cao J; Chow L; Dow S
    Front Oncol; 2023; 13():1116016. PubMed ID: 37114134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Double Strike Approach for Tumor Attack: Engineering T Cells Using a CD40L:CD28 Chimeric Co-Stimulatory Switch Protein for Enhanced Tumor Targeting in Adoptive Cell Therapy.
    Olguín-Contreras LF; Mendler AN; Popowicz G; Hu B; Noessner E
    Front Immunol; 2021; 12():750478. PubMed ID: 34912334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Critical Role for the Adenosine Pathway in Controlling Simian Immunodeficiency Virus-Related Immune Activation and Inflammation in Gut Mucosal Tissues.
    He T; Brocca-Cofano E; Gillespie DG; Xu C; Stock JL; Ma D; Policicchio BB; Raehtz KD; Rinaldo CR; Apetrei C; Jackson EK; Macatangay BJ; Pandrea I
    J Virol; 2015 Sep; 89(18):9616-30. PubMed ID: 26178986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemerin Suppresses Breast Cancer Growth by Recruiting Immune Effector Cells Into the Tumor Microenvironment.
    Pachynski RK; Wang P; Salazar N; Zheng Y; Nease L; Rosalez J; Leong WI; Virdi G; Rennier K; Shin WJ; Nguyen V; Butcher EC; Zabel BA
    Front Immunol; 2019; 10():983. PubMed ID: 31139180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting CD73 with AB680 (Quemliclustat), a Novel and Potent Small-Molecule CD73 Inhibitor, Restores Immune Functionality and Facilitates Antitumor Immunity.
    Piovesan D; Tan JBL; Becker A; Banuelos J; Narasappa N; DiRenzo D; Zhang K; Chen A; Ginn E; Udyavar AR; Yin F; Paprcka SL; Purandare B; Park TW; Kimura N; Kalisiak J; Young SW; Powers JP; Schindler U; Sivick KE; Walters MJ
    Mol Cancer Ther; 2022 Jun; 21(6):948-959. PubMed ID: 35405741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.